490330·Stock-Sector-Healthcare
KoAct US CNS Therapeutics Active
Introduction
The KoAct US Brain Treatment Active ETF aims to outperform the Solactive US CNS Therapeutics Index PR by actively adjusting weightings and selectively including non-benchmark asset in its portfolio
Investment Points
An ETF that invests in companies providing products or services contributing to the treatment of neurodegenerative diseases, mental disorders, and other brain-related conditions such as epilepsy
Benchmark Index
Solactive US CNS Therapeutics Index PR
Benchmark Index Description
An index composed of companies listed on the U.S. stock market that are involved in the brain disease treatment industry
Issuer
Samsung Active Asset Management
Brand
KoAct
Total Fee
0.5
Listing Date
2024-09-03
International Securities Code
KR7490330008
Market Information
Market Capitalization
9,558,000,000KRW
Transaction Amount
46,314,870KRW
Trading Volume
4,347
Shares Outstanding
900,000
NAV
10,675
52-Week High
11,300KRW
52-Week Low
9,340KRW